Serum serotonin levels are associated with antiviral therapy outcomes in patients with chronic hepatitis C

Jennifer Loftis, Benjamin Morasco, Daniel Menasco, Dietmar Fuchs, Max Strater, Peter Hauser

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The role of serotonin in contributing to viral clearance has not been investigated in patients with chronic hepatitis C (HCV). In this prospective study we collected blood samples from 39 patients prior to and during antiviral therapy. Participants completed mood rating scales to monitor psychiatric symptoms, and serum serotonin and tryptophan levels were measured. Significant differences in serotonin levels were found between patients who achieved sustained viral responses (SVRs) and those who did not. Regression analysis revealed that serotonin was the only variable with a statistically significant relationship with antiviral therapy outcomes, even after controlling for other variables known to be associated with outcomes. Baseline serum serotonin levels, in combination with other variables such as degree of liver fibrosis, may be clinically useful for identifying patients in whom HCV can be cleared by antiviral therapy. Additional clinical predictors that could forecast treatment success are needed so that interventions to improve SVR rates, and reduce side effects, can be developed.

Original languageEnglish (US)
Pages (from-to)132-141
Number of pages10
JournalOpen Infectious Diseases Journal
Volume4
Issue number1
DOIs
StatePublished - 2010

Fingerprint

Chronic Hepatitis C
Antiviral Agents
Serotonin
Serum
Therapeutics
Tryptophan
Liver Cirrhosis
Psychiatry
Regression Analysis
Prospective Studies

Keywords

  • 3-dioxygenase
  • Depression
  • HCV
  • Indolamine 2
  • Interferon sustained viral response
  • Tryptophan

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology
  • Parasitology

Cite this

Serum serotonin levels are associated with antiviral therapy outcomes in patients with chronic hepatitis C. / Loftis, Jennifer; Morasco, Benjamin; Menasco, Daniel; Fuchs, Dietmar; Strater, Max; Hauser, Peter.

In: Open Infectious Diseases Journal, Vol. 4, No. 1, 2010, p. 132-141.

Research output: Contribution to journalArticle

@article{db099b94016d4362849bed6838b3048e,
title = "Serum serotonin levels are associated with antiviral therapy outcomes in patients with chronic hepatitis C",
abstract = "The role of serotonin in contributing to viral clearance has not been investigated in patients with chronic hepatitis C (HCV). In this prospective study we collected blood samples from 39 patients prior to and during antiviral therapy. Participants completed mood rating scales to monitor psychiatric symptoms, and serum serotonin and tryptophan levels were measured. Significant differences in serotonin levels were found between patients who achieved sustained viral responses (SVRs) and those who did not. Regression analysis revealed that serotonin was the only variable with a statistically significant relationship with antiviral therapy outcomes, even after controlling for other variables known to be associated with outcomes. Baseline serum serotonin levels, in combination with other variables such as degree of liver fibrosis, may be clinically useful for identifying patients in whom HCV can be cleared by antiviral therapy. Additional clinical predictors that could forecast treatment success are needed so that interventions to improve SVR rates, and reduce side effects, can be developed.",
keywords = "3-dioxygenase, Depression, HCV, Indolamine 2, Interferon sustained viral response, Tryptophan",
author = "Jennifer Loftis and Benjamin Morasco and Daniel Menasco and Dietmar Fuchs and Max Strater and Peter Hauser",
year = "2010",
doi = "10.2174/1874279301004010132",
language = "English (US)",
volume = "4",
pages = "132--141",
journal = "Open Infectious Diseases Journal",
issn = "1874-2793",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Serum serotonin levels are associated with antiviral therapy outcomes in patients with chronic hepatitis C

AU - Loftis, Jennifer

AU - Morasco, Benjamin

AU - Menasco, Daniel

AU - Fuchs, Dietmar

AU - Strater, Max

AU - Hauser, Peter

PY - 2010

Y1 - 2010

N2 - The role of serotonin in contributing to viral clearance has not been investigated in patients with chronic hepatitis C (HCV). In this prospective study we collected blood samples from 39 patients prior to and during antiviral therapy. Participants completed mood rating scales to monitor psychiatric symptoms, and serum serotonin and tryptophan levels were measured. Significant differences in serotonin levels were found between patients who achieved sustained viral responses (SVRs) and those who did not. Regression analysis revealed that serotonin was the only variable with a statistically significant relationship with antiviral therapy outcomes, even after controlling for other variables known to be associated with outcomes. Baseline serum serotonin levels, in combination with other variables such as degree of liver fibrosis, may be clinically useful for identifying patients in whom HCV can be cleared by antiviral therapy. Additional clinical predictors that could forecast treatment success are needed so that interventions to improve SVR rates, and reduce side effects, can be developed.

AB - The role of serotonin in contributing to viral clearance has not been investigated in patients with chronic hepatitis C (HCV). In this prospective study we collected blood samples from 39 patients prior to and during antiviral therapy. Participants completed mood rating scales to monitor psychiatric symptoms, and serum serotonin and tryptophan levels were measured. Significant differences in serotonin levels were found between patients who achieved sustained viral responses (SVRs) and those who did not. Regression analysis revealed that serotonin was the only variable with a statistically significant relationship with antiviral therapy outcomes, even after controlling for other variables known to be associated with outcomes. Baseline serum serotonin levels, in combination with other variables such as degree of liver fibrosis, may be clinically useful for identifying patients in whom HCV can be cleared by antiviral therapy. Additional clinical predictors that could forecast treatment success are needed so that interventions to improve SVR rates, and reduce side effects, can be developed.

KW - 3-dioxygenase

KW - Depression

KW - HCV

KW - Indolamine 2

KW - Interferon sustained viral response

KW - Tryptophan

UR - http://www.scopus.com/inward/record.url?scp=84861409865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861409865&partnerID=8YFLogxK

U2 - 10.2174/1874279301004010132

DO - 10.2174/1874279301004010132

M3 - Article

AN - SCOPUS:84861409865

VL - 4

SP - 132

EP - 141

JO - Open Infectious Diseases Journal

JF - Open Infectious Diseases Journal

SN - 1874-2793

IS - 1

ER -